MetLife Investment Management, LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,488,277

+$1,447,408 QoQ

Shares Held

26,281

+8.4% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#140

of 288 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. APGE ranks #28 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,488,277	26,281	+8.4%	Shares	Defined	2026-08-14
2026-03-31	$2,040,869	24,247	+13.8%	Shares	Defined	2026-05-14
2025-12-31	$1,608,554	21,311	+10.8%	Shares	Defined	2026-02-12
2025-09-30	$764,325	19,238	0.0%	Shares	Defined	2025-11-13
2025-06-30	$835,506	19,238	-14.9%	Shares	Defined	2025-08-13
2025-03-31	$844,522	22,605	-1.5%	Shares	Defined	2025-05-14
2024-12-31	$1,040,088	22,960	+8.7%	Shares	Defined	2025-02-13
2024-09-30	$1,240,295	21,115	+0.4%	Shares	Defined	2024-11-13
2024-06-30	$827,727	21,035	-0.9%	Shares	Defined	2024-08-13
2024-03-31	$1,410,667	21,229	+99.6%	Shares	Defined	2024-05-14
2023-12-31	$297,225	10,638	0.0%	Shares	Defined	2024-04-22
2023-09-30	$226,589	10,638	—	Shares	Defined	2024-05-09
No filing history on record for this holder in this stock.